These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 1867865

  • 1. In vivo sodium-23 MRI in brain tumors: evaluation of preliminary clinical experience.
    Hashimoto T, Ikehira H, Fukuda H, Yamaura A, Watanabe O, Tateno Y, Tanaka R, Simon HE.
    Am J Physiol Imaging; 1991; 6(2):74-80. PubMed ID: 1867865
    [Abstract] [Full Text] [Related]

  • 2. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH.
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [Abstract] [Full Text] [Related]

  • 3. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T, Yamada K, Kizu O, Hirota T, Ito H, Ishihara K, Nishimura T.
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [Abstract] [Full Text] [Related]

  • 4. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
    Oh J, Cha S, Aiken AH, Han ET, Crane JC, Stainsby JA, Wright GA, Dillon WP, Nelson SJ.
    J Magn Reson Imaging; 2005 Jun; 21(6):701-8. PubMed ID: 15906339
    [Abstract] [Full Text] [Related]

  • 5. Preoperative imaging of superficially located glioma resection using short inversion-time inversion recovery images in high-field magnetic resonance imaging.
    Beppu T, Inoue T, Nishimoto H, Ogasawara K, Ogawa A, Sasaki M.
    Clin Neurol Neurosurg; 2007 May; 109(4):327-34. PubMed ID: 17275995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Diffusion weighted MR: principles and clinical use in selected brain diseases].
    Nistri M, Mascalchi M, Moretti M, Tessa C, Politi LS, Orlandi I, Pellicanò G, Villari N.
    Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509
    [Abstract] [Full Text] [Related]

  • 9. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging.
    Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA.
    Radiology; 2003 May; 227(2):529-37. PubMed ID: 12663825
    [Abstract] [Full Text] [Related]

  • 10. [The application of in vivo diffusion weighted magnetic resonance imaging to intracranial disorders].
    Ebisu T, Naruse S, Horikawa Y, Ueda S, Tanaka C, Umeda M, Higuchi T, Shimizu K, Nishimura N, Okamura S.
    No To Shinkei; 1991 Jul; 43(7):677-84. PubMed ID: 1910953
    [Abstract] [Full Text] [Related]

  • 11. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M, Bockhorst K.
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of peritumoral edema by proton T1 values with special remarks on time courses following intracranial surgery].
    Yoshida K, Inao S, Saso K, Motegi Y, Kaneoke Y, Furuse M.
    No Shinkei Geka; 1987 Apr; 15(4):389-95. PubMed ID: 3614531
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H, Enmi J, Teramoto N, Hayashi T, Yamamoto A, Tsuji T, Naito H, Iida H.
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [Abstract] [Full Text] [Related]

  • 14. [FLAIR images of brain diseases].
    Segawa F, Kishibayashi J, Kamada K, Sunohara N, Kinoshita M.
    No To Shinkei; 1994 Jun; 46(6):531-8. PubMed ID: 8068434
    [Abstract] [Full Text] [Related]

  • 15. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
    Kumar A, Kaushik S, Tripathi RP, Kaur P, Khushu S.
    Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Magnetic resonance imaging of brain tumors].
    Takahashi M.
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3209-18. PubMed ID: 3318701
    [Abstract] [Full Text] [Related]

  • 18. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
    Tovi M, Hartman M, Lilja A, Ericsson A.
    Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
    [Abstract] [Full Text] [Related]

  • 19. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [Abstract] [Full Text] [Related]

  • 20. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
    Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller HW.
    J Magn Reson Imaging; 2004 Nov; 20(5):758-64. PubMed ID: 15503327
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.